Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEMIPLIMAB-RWLC: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

40.6%
Female
59.4%
Male

Age Information

The average age of patients reporting adverse events with CEMIPLIMAB-RWLC is 70.2 years.

Geographic Distribution

The majority of adverse event reports for CEMIPLIMAB-RWLC originate from US.

Report Summary & Outcomes

1,554
Total Reports
1,554
As Primary/Secondary Suspect
323
Deaths Reported
441
Hospitalizations
90
Life-Threatening
24
Disabilities

Reporting Timeline

First adverse event report: 20121206. Most recent report: 20250801. View full timeline →

More About CEMIPLIMAB-RWLC

CEMIPLIMAB-RWLC Full Profile Reports by Year Drug Interactions